James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $569.24 ($5.7M) on 2026-04-30, disclosed to the SEC on 2026-05-01.
Scheduled sale ($5.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $569.24 | 262 | $149K | 2.6% |
| 2 | $570.19 | 484 | $276K | 4.8% |
| 3 | $571.23 | 2,940 | $1.7M | 29.3% |
| 4 | $572.00 | 3,034 | $1.7M | 30.3% |
| 5 | $573.00 | 880 | $504K | 8.8% |
| 6 | $574.07 | 887 |
| $509K |
| 8.9% |
| 7 | $574.96 | 273 | $157K | 2.7% |
| 8 | $576.24 | 486 | $280K | 4.9% |
| 9 | $577.24 | 336 | $194K | 3.4% |
| 10 | $578.07 | 378 | $219K | 3.8% |
| 11 | $578.76 | 40 | $23K | 0.4% |
| Total | $572.61 avg | 10,000 | $5.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |